Biotech

All Articles

Cullinan, after $25M package, hands back bispecific to Port

.Cullinan Rehab was actually wowed good enough with Harbour BioMed's bispecific immune reactor that ...

A more detailed look at Strong Biotech's Brutal 15

.In this particular full week's incident of "The Best Pipe," our experts're diving right into Intens...

Lilly deals with phase 2 breakdown of tau-targeting med

.The confetti is still flying coming from Eli Lilly's gathering commemorating the approval of Alzhei...

Biogen CMO Maha Radhakrishnan participates in Sofinnova-- Chutes &amp Ladders

.Invite to recently's Chutes &amp Ladders, our summary of notable leadership hirings, firings and al...

Lykos will certainly ask FDA to reevaluate its own selection observing rejection of MDMA treatment for post-traumatic stress disorder

.Observing an inadequate presenting for Lykos Therapies' MDMA prospect for trauma at a current FDA c...

AN 2 halves headcount, quits phase 3 test after records dissatisfy

.AN2 Therapeutics is actually reviewing its own service in response to lackluster midphase records, ...

Merck pays out $700M for bispecific, snooping autoimmune position and also opportunity to challenge Amgen in cancer cells

.Merck &amp Co. is paying $700 million ahead of time to challenge Amgen in a blood cancer cells mark...

Gilead pays out J&ampJ $320M to exit licensing offer for seladelpar

.With Gilead Sciences on the verge of an FDA decision for its liver health condition medicine selade...

' All hands on deck' at Lilly as peers target weight problems market

.Chief executive officer David Ricks can view the companies setting up camping tents at basecamp res...

Entero laying off personnel, moving out of workplace as well as stopping R&ampD

.Bed Liquidators has turned Entero Therapies white as a sheet. The creditor got Entero to repay its ...